Two Sigma Investments
FTH

Two Sigma Investments’s Faeth Therapeutics FTH Stock Holding History

Two Sigma Investments’s Portfolio FTH Stock Details FTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-509
Closed -$10.7K – 3307
2024
Q1 		$10.7K Hold
509
– – ﹤0.01% 2949
2023
Q4 		$7.04K Sell
509
-35
-6% -$478 ﹤0.01% 3096
2023
Q3 		$8.7K Sell
544
-135
-20% -$2.9K ﹤0.01% 2903
2023
Q2 		$15.5K Sell
679
-85
-11% -$2.49K ﹤0.01% 2927
2023
Q1 		$22.9K Sell
764
-790
-51% -$23.4K ﹤0.01% 2843
2022
Q4 		$46.3K Sell
1,554
-235
-13% -$6.91K ﹤0.01% 2602
2022
Q3 		$55K Sell
1,789
-150
-8% -$5.89K ﹤0.01% 2306
2022
Q2 		$88K Sell
1,939
-1,170
-38% -$43.8K ﹤0.01% 2280
2022
Q1 		$144K Buy
3,109
+1,670
+116% +$133K ﹤0.01% 2387
2021
Q4 		$167K Buy
+1,439
New +$215K ﹤0.01% 3970
2021
Q3 		– Sell
-928
Closed -$181K – 4660
2021
Q2 		$181K Sell
928
-1,378
-60% -$340K ﹤0.01% 3808
2021
Q1 		$670K Buy
+2,306
New +$772K ﹤0.01% 2661

Other funds holding FTH

IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Cresset Asset Management Chicago, Illinois $23.1B AUM 27.04% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Two Sigma Investments's FTH Position: Q2 2024 in Review

Two Sigma Investments sold out of Faeth Therapeutics (FTH) in Q2 2024, closing a stake of 509 shares — an estimated $10.7K sold.

Two Sigma Investments first reported a position in FTH in Q1 2021 and held it in 12 quarters. The position peaked at $670K in Q1 2021. 23 funds tracked by Wall St. Rank hold FTH as of Q2 2024.

  • Two Sigma Investments reported no remaining Faeth Therapeutics position as of Q2 2024 after selling out during the quarter.
  • Two Sigma Investments sold 509 Faeth Therapeutics shares in Q2 2024, an estimated $10.7K.
  • Two Sigma Investments first reported a position in Faeth Therapeutics in Q1 2021 and held it in 12 quarters.
  • Two Sigma Investments's Faeth Therapeutics position peaked at $670K in Q1 2021.
  • 23 funds tracked by Wall St. Rank held Faeth Therapeutics as of Q2 2024.

Based on Two Sigma Investments's 13F filing for Q2 2024, filed 14 Aug 2024.